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The α9 and α10 nicotinic cholinergic 
subunits assemble to form the receptor believed 
to mediate synaptic transmission between 
efferent olivocochlear fibers and hair cells of 
the cochlea, one of the few examples of 
postsynaptic function for a non-muscle 
nicotinic acetylcholine receptor (nAChR). 
However, it has been suggested that the 
expression profile of α9 and α10 overlaps with 
that of α7 in the cochlea and in sites like dorsal 
root ganglion neurons, peripheral blood 
lymphocytes, developing thymocytes and skin. 
We now report the cloning, total synthesis and 
characterization of a novel toxin α-conotoxin 
PeIA that discriminates between α9α10 and α7 
nAChRs. This is the first toxin to be identified 
from Conus pergrandis, a species found in deep 
waters of the Western Pacific. α-Conotoxin 
PeIA displayed a 260-fold higher selectivity for 
α-bungarotoxin-sensitive α9α10 nAChRs 
compared to α-bungarotoxin-sensitive α7 
receptors.  The IC50 of the toxin was 6.9 ± 0.5 
nM and 4.4 ± 0.5 nM, for recombinant α9α10 
and wild-type hair cell nAChRs, respectively. 
α-Conotoxin PeIA bears high resemblance to α-
conotoxins MII and GIC isolated from Conus 
magus and Conus geographus, respectively. 
However, neither α-conotoxin MII nor α-
conotoxin GIC at concentrations of 10 µM, 
blocked acetylcholine responses elicited in 
Xenopus oocytes injected with the α9 and α10 
subunits. Among neuronal non-α-bungarotoxin 
sensitive receptors, α-conotoxin PeIA was also 
active at α3β2 receptors and chimeric 
α6/α3β2β3 receptors. α-conotoxin PeIA 
represents a novel probe to differentiate 
responses mediated either through α9α10 or α7 
nAChRs in those tissues where both receptors 
are expressed. 
Nicotinic acetylcholine receptors 
(nAChRs)1 are widely distributed in both the 
central and peripheral nervous system.  In 
vertebrates, nine α subunits (α2-α10) and three β 
subunits (β2-β4) have been cloned.  The rules of 
association for functional nAChRs are broadening, 
and now permit receptors assembled from single α 
subunits (α7, α8 and α9)(1-3); receptors which 
contain multiple α subunits both with (α2α5β2, 
α3α5β2, α3α5β4, α4α5β2) (4-6) and without 
supplemental β subunits (α7α8, α9α10) (2, 7); 
 JBC Papers in Press. Published on June 27, 2005 as Manuscript M504102200
 Copyright 2005 by The American Society for Biochemistry and Molecular Biology, Inc.
 by guest on July 19, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
α-CTx PeIA discriminates between α9α10 and α7 nAChRs 
2 
receptors with single α and multiple β subunits 
(α3β2β4, α3β3β4) (8, 9); receptors with multiple 
α and β subunits (α3β2β4α5, α4α6β2β3) (10-12); 
as well as heteromeric nAChRs formed via 
pairwise combinations of α2, α3, α4 or α6 with 
either the β2 or β4 subunits (13-17).  Thus, the 
number of potential molecular forms of nicotinic 
receptors is very large.  Elucidation of the precise 
structure and function of various neuronal 
nAChRs in vivo is particularly challenging, in part 
because of the scarcity of ligands selective for 
specific receptor subtypes. 
 The venoms of predatory cone snails 
(Conus) represent a rich combinatorial-like library 
of evolutionarily selected, neuropharmacologically 
active peptides (18).  There are more than 500 
species of these snails.  Each Conus venom 
appears to contain a unique set of 50-200 small 
disulfide-bonded peptides that target receptors and 
ion channels in a highly subtype-selective manner.  
For peptides where function has been determined, 
three classes of targets have been elucidated:  
voltage-gated ion channels, G-protein-coupled 
receptors and ligand-gated ion channels (19).  
Perhaps the most conserved feature of cone snail 
venom is the α-conotoxins; these are a series of 
structurally and functionally related peptides that 
target nAChRs.  Every venom examined thus far 
has its own distinct complement of nicotinic 
receptor antagonists, suggesting that, within the 
genus, there are literally thousands of novel 
peptides that act on nAChRs. A major advance in 
recent years in the neuropharmacology of nAChRs 
has been the ability to more readily characterize 
particular neuronal subtypes by using specific 
conotoxins. 
 We now report the cloning of a gene 
encoding a novel peptide of the α-conotoxin 
family from Conus pergrandis, α-conotoxin PeIA 
(α-CTx PeIA).  As far as we are aware, this is the 
first toxin to be characterized from this species 
found in deep waters (50-530 m) of the Western 
Pacific. We show that the peptide has unusual 
targeting specificity; it has high affinity for 
recombinant α9α10-containing nAChR receptors, 
and can readily discriminate this α-bungarotoxin-
sensitive receptor from the neuronal α7 α-
bungarotoxin-sensitive receptor. In addition, α-
CTx PeIA blocks native cochlear hair cell 
nAChRs with a high potency, demonstrating an in 
vivo target for the peptide. Thus, α-CTx PeIA can 
be used to selectively discern between α9α10- and 
α7-mediated functions at those sites where both 
types of receptors are expressed. 
 
EXPERIMENTAL PROCEDURES 
 
Identification and Sequencing of Genomic 
Clones Encoding α-CTx PeIA-Genomic DNA was 
prepared from 50 mg of Conus pergrandis 
hepatopancreas using the Gentra PUREGENE 
DNA Isolation Kit (Gentra Systems, Minneapolis, 
MN), according to the manufacturer’s standard 
protocol. It was used as a template for polymerase 
chain reaction (PCR) with oligonucleotides 
corresponding to the conserved intron and 3’ UTR 
sequences of α-conotoxin prepropeptides.  The 
resulting PCR products were purified using the 
High Pure PCR Product Purification Kit (Roche 
Diagnostics, Indianapolis, IN).  The eluted DNA 
fragments were annealed to pAMP1 vector, and 
the resulting products transformed into competent 
DH5α cells using the CloneAmp pAMP System 
for Rapid Cloning of Amplification Products (Life 
Technologies/Gibco BRL, Grand Island, NY).  
The nucleic acid sequences of the resulting α-
conotoxin-encoding clones were determined 
according to the standard protocol for automated 
sequencing.   
Chemical synthesis−α-CTx PeIA (0.45 
mmol/g) was synthesized on an amide resin using 
Fmoc chemistry and standard side protection, 
except on cysteine residues.  Cys residues were 
protected in pairs with either S-trityl on Cys2 and 
Cys8, or S-acetamidomethyl on Cys3 and Cys16.  
The peptide was removed from the resin and 
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precipitated.  A two-step oxidation protocol was 
used to selectively fold the peptides as described 
previously (20). Briefly, the disulfide bridge 
between Cys2 and Cys8 was closed by dripping the 
peptide into an equal volume of 20 mM potassium 
ferricyanide, 0.1 M Tris, pH 7.5.  The solution was 
allowed to react for 30 min, and the monocyclic 
peptide was purified by reverse-phase HPLC.  
Simultaneous removal of the S-acetamidomethyl 
groups and closure of the disulfide bridge between 
Cys3 and Cys16 was carried out by iodine 
oxidation.  The monocyclic peptide and HPLC 
eluent were dripped into an equal volume of iodine 
(10 mM) in H20:trifluoroacetic acid:acetonitrile 
(78:2:20 by volume), and allowed to react for 10 
min.  The reaction was terminated by the addition 
of ascorbic acid, diluted 20-fold with 0.1% 
trifluoroacetic acid, and the bicyclic peptide was 
purified by HPLC on a reverse-phase C18 Vydac 
column using a linear gradient of 0.1% 
trifluoroacetic acid 0.092% trifluoroacetic acid, 
60% acetonitrile,  remainder H2O. 
Mass spectrometry-Matrix-assisted laser 
desorption ionization (MALDI) time-of-flight 
mass spectrometry was utilized. 
Expression of recombinant receptors in 
Xenopus laevis oocytes-Capped cRNAs were in 
vitro-transcribed from linearized rat plasmid DNA 
templates using the mMessage mMachine 
Transcription Kit (Ambion Corporation, Austin, 
TX).  The maintenance of Xenopus laevis, as well 
as the preparation and cRNA injection of stage V 
and VI oocytes has been described in detail 
elsewhere (21). Typically, oocytes were injected 
with 50 nl of RNase-free water containing 0.01-
1.0 ng of cRNAs (at a 1:1 molar ratio when 
pairwise combined), and maintained in Barth's 
solution at 17° C. 
Electrophysiological recordings were 
performed 2-6 days after cRNA injection under 
two-electrode voltage-clamp with an OC-725B 
oocyte clamp (Warner Instruments, Wamden, CT).  
Both voltage and current electrodes were filled 
with 3M KCl, and had resistances of ~1-2 MΩ.  
Data were digitized and stored on a PC computer.  
Data were analyzed using Clamp Fit from the 
pClamp 6 software (Axon Instruments Corp., 
Union City, CA).  During electrophysiological 
recordings, oocytes were continuously superfused 
(~10 ml/min) with normal frog saline (comprised 
of, in mM):  115 NaCl, 2.5 KCl, 1.8 CaCl2, and 10 
HEPES buffer, pH 7.2, and voltage-clamped at -70 
mV.  In order to follow the same conditions we 
have previously employed to analyze the 
properties of α9α10 nAChRs (7), when expressing 
α9α10, experiments were performed in oocytes 
incubated with the Ca2+ chelator 1,2-bis(2-
aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-
acetoxymethyl ester (BAPTA-AM, 100 µM) for 3-
4 hr prior to electrophysiological recordings.  
Drugs were applied in the perfusion solution of the 
oocyte chamber.  All toxin solutions also 
contained 0.1 mg/ml bovine serum albumin to 
reduce nonspecific adsorption of peptide.  The 
toxin was pre-applied for 10 min prior to the 
addition of the agonist.  For the construction of the 
inhibition curves, the concentration of 
acetylcholine (ACh) used was near the 
corresponding EC50 for each receptor; i.e., α9α10, 
10 µM; α7, 100 µM; α3β2, 10 µM; α3β4, 100 
µM; α4β2, 10 µM.  
Recordings from inner hair cells-Apical 
turns of the organ of Corti were excised from 
Sprague-Dawley rats at postnatal ages 8 to 10.  
Cochlear preparations were mounted under an 
Axioskope microscope (Zeiss, Oberkochem, 
Germany), and viewed with differential 
interference contrast (DIC) using a 63x water 
immersion objective and a camera with contrast 
enhancement (Hamamatsu C2400-07, Hamamatsu 
City, Japan).  Methods to record from inner hair 
cells were essentially as described (22).  Briefly, 
inner hair cells were identified visually, by the size 
of their capacitance (7 to 12 pF) and by their 
characteristic voltage-dependent Na+ and K+ 
currents, including at older ages a fast-activating 
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K+-conductance (23).  Some cells were removed to 
access inner hair cells, but mostly the pipette 
moved through the tissue using positive fluid flow 
to clear the tip.  The extracellular solution was as 
follows (in mM): 155 NaCl, 5.8 KCl, 1.3 CaCl2, 
0.9 MgCl2, 0.7 NaH2PO4, 5.6 D-glucose, and 10 
Hepes buffer; pH 7.4.  The pipette solution was (in 
mM): 150 KCl, 3.5 MgCl2, 0.1 CaCl2, 10 1,2-
bis(2-aminophenoxy)ethane-N,N,N´,N´-tetraacetic 
acid (BAPTA), 5 Hepes buffer, 2.5 Na2ATP, pH 
7.2.  Glass pipettes (1.2 mm i.d.) had resistances of 
7-10 MΩ.  Cells were held at a holding potential 
of -90 mV.  Postsynaptic currents due to the 
spontaneous release of ACh from efferent synaptic 
terminals contacting inner hair cells are 
occasionally observed. Therefore, in order to study 
the effect of the toxin on synaptic currents in these 
cells, transmitter release from efferent endings was 
accelerated by depolarization using 25 mM 
external potassium saline. In this case, the pipette 
solution was (in mM): 150 KCl, 3.5 MgCl2, 0.1 
CaCl2, 5 ethyleneglycol-bis(β-aminoethyl ether)-
N,N,N´,N´- tetraacetic acid (EGTA), 5 Hepes 
buffer, 2.5 Na2ATP, pH 7.2. Solutions containing 
60 µM ACh (the EC50 in this preparation) or 
elevated potassium (25 mM K+) and the toxin 
were applied by a gravity-fed multi-channel glass 
pipette (∼150 µm tip diameter) positioned about 
300 µm from the recorded inner hair cell. All toxin 
solutions also contained 0.1 mg/ml bovine serum 
albumin to reduce nonspecific adsorption of 
peptide.  The extracellular solution containing the 
drugs was similar to that described above, except 
that Mg2+ was omitted, and the Ca2+ concentration 
was lowered to 0.5 mM to optimize the 
experimental conditions for measuring currents 
flowing through the α9α10 receptors (24, 25). To 
minimize the contribution of SK channel currents, 
1 nM apamin, a specific SK channel blocker, was 
added to the external working solutions.  Currents 
in inner hair cells were recorded in the whole-cell 
patch-clamp mode using (Axopatch 200B 
amplifier) low-pass filtered at 2-10 kHz and 
digitized at 5-20 kHz with a Digidata 1200 board 
(Axon Instruments, Union City, CA).  Recordings 
were made at room temperature (22-25 ºC).  
Voltages were not corrected for the voltage drop 
across the uncompensated series resistance. 
For constructing the inhibition curves, 
both in oocytes and the cochlear preparation, the 
average peak amplitude of three control responses 
just before the exposure to the toxin was used to 
normalize the amplitude of each test response in 
the presence of the toxin.  Each data point of the 
inhibition curves represents the average value ± 
S.E.M of measurements from at least three 
experiments.  Curves were fitted with the 
following equation:  % response = 100 / (1 + 
[(T)/IC50]nH), where nH is the Hill coefficient, T 
the concentration of toxin, and IC50 the 
concentration of toxin that reduces to 50% the 
maximal response to ACh.  
Statistical Analysis-Statistical significance 
was evaluated by the Student's t test (two-tailed, 
unpaired samples). A p<0.05 was considered 
significant. 
 
RESULTS 
 
 Cloning of α-CTx PeIA-Although the 
mature α-conotoxin sequences are highly variable, 
the organization of their encoding genes is 
constant across species.  The α-conotoxins are 
proteolytically cleaved from a larger precursor 
protein. This prepropeptide is approximately 40 
amino acids long, with the mature α-conotoxin 
moiety of ~13-18 amino acids located at the 
carboxy-terminus of the precursor.  A basic amino 
acid, immediately preceding the mature toxin in 
the precursor sequence, acts as a processing site.  
In contrast to the highly variable sequence of the 
mature toxins, the precursor proteins of α-
conotoxins are highly conserved. The signal 
sequence region is practically invariant among the 
different α-conotoxin precursors, even in distantly 
related Conus species.  Also, sequence segments 
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in the 3’ untranslated region (UTR) of the α-
conotoxin mRNA and in the intron immediately 
preceding the toxin sequence are similarly 
conserved (18). We utilized conserved intronic 
and 3’ UTR sequences of the α-conotoxin gene 
structure to design oligonucleotide primers for 
polymerase chain reaction amplification of the α-
conotoxin-coding region. The resulting sequence 
from Conus pergrandis is shown in Fig. 1.  The 
toxin was named α-conotoxin PeIA (“Pe” 
designating the species, pergrandis; Roman 
numeral “I” to designate the canonical α-
conotoxin disulfide bond pattern; and “A” to 
indicate that it is the first α-conotoxin reported 
from this species). 
 Chemical synthesis of α-CTx PeIA- Solid-
phase chemical synthesis of the predicted mature 
toxin was performed.  In synthesizing the peptide, 
it was assumed that the disulfide bridging pattern 
of α-CTx PeIA was the same as all previously 
characterized α-conotoxins, that is, Cys2 to Cys8 
and Cys3 to Cys16 (18).The glycine at the C-
terminus was assumed to be posttranslationally 
modified to a C-terminal amide.  Cys groups were 
orthogonally protected in pairs to direct disulfide 
bond formation.  Acid-labile S-trityl groups were 
removed simultaneously with peptide cleavage 
from the resin, and closure of the disulfide bridge 
between these Cys residues was accomplished 
with FeCN.  The single-bridge peptide was 
purified by HPLC, and the acid-stable 
acetomidomethyl groups were removed; the 
disulfide bridges formed by iodine oxidation.  The 
bicyclic peptide was subsequently purified by 
HPLC and analyzed with MALDI mass 
spectrometry.  The mass of the synthetic peptide 
was consistent with the amidated sequence 
(monoisotopic MH+:  calculated, 1651.62; 
observed, 1651.6).  This synthesized toxin was 
utilized in all subsequent experiments. 
Effect of α-CTx PeIA on ACh-evoked 
currents through nAChRs-Conotoxins have been 
widely used as a pharmacological tool to 
characterize neuronal nAChRs (26).  We therefore 
decided to analyze the effects of α-CTx PeIA on 
different nAChRs. Figure 2A shows representative 
responses of Xenopus laevis oocytes expressing 
either the α-bungarotoxin-sensitive α9α10 or α7 
nAChRs to ACh, and blockage of responses in the 
presence of α-CTx PeIA. Complete block of ACh-
evoked currents was obtained with 0.3 µM α-CTx 
PeIA in the case of α9α10, compared to 100 µM 
in the case of α7 nAChRs. As derived from the 
inhibition curves in Fig. 2B, currents elicited by 
ACh in α9α10 nAChRs were potently blocked by 
α-CTx PeIA with a mean IC50 and S.E.M. of 6.9 ± 
0.5 nM (n = 6).  In the case of α7, the IC50 value, 
1.8 ± 0.1 µM (n = 5), was 260-fold higher than 
that obtained for α9α10, thus indicating a high 
degree of selectivity of the toxin for α9α10.  The 
blockage produced by α-CTx PeIA on both types 
of receptors was reversible after washing with 
saline solution.  Figure 3 shows the washout 
kinetics in the case of α9α10.  The effect of α-
CTx PeIA was reversed relatively rapidly:  >50% 
recovery in 3 minutes, and total recovery after 12-
15 minutes. 
Cochlear outer and developing inner hair cells are 
the main targets of descending cholinergic 
olivocochlear efferent fibers (27). The efferent 
fibers-hair cell synapse is most likely mediated by 
α9α10 nAChRs (7, 28, 29), providing one of the 
few postsynaptic functions for non-muscle 
nAChRs.  However, α7 transcripts as well as α7 
immunostaining have been reported in the 
mammalian organ of Corti  (30, 31). Recordings 
from inner hair cells are an excellent tool to 
evaluate the effects of the toxin in native hair cell 
nAChRs.  As shown in Fig. 4 A, α-CTx PeIA 
potently blocked ACh-evoked responses in inner 
hair cells. The IC50 value obtained, 4.4 ± 0.5 nM, 
was similar to that found in recombinant α9α10 
receptors, thus confirming the α9α10 identity of 
this nAChR.  
The physiologic conditions of 
neurotransmission in vivo, for instance a synaptic 
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regime, notably differ from the conditions of the 
oocyte recording or of a bath application of ACh 
to the organ of Corti. Transmitter released in a 
synaptic cleft, in close proximity to postsynaptic 
receptors reaches millimolar ranges, sufficient to 
activate in the millisecond range receptors with a 
low affinity active state and a fast desensitization 
rate (32). We therefore studied the effect of α-CTx 
PeIA on synaptic currents evoked by the release of 
presynaptic ACh in the presence of 25 mM KCl. 
As observed in Fig. 5, 30 nM α-CTx PeIA also 
blocked responses to synaptically released ACh, 
thus indicating that the toxin is a valuable tool to 
examine in vivo responses mediated through 
α9α10 receptors. Figure 5A shows K+-evoked 
synaptic currents either in the absence or presence 
of α-CTx PeIA. The blocking effect of the toxin 
was rapidly reversible upon washing the 
preparation. The effect of α-CTx PeIA was a 
reduction of the amplitude (Fig. 5B) of the 
synaptic currents (from 57.0 ± 0.7 pA, number of 
events: 997, number of cells: 3, to 37.5 ± 0.7 pA, 
number of events: 766, number of cells: 3, p< 
0.0001). This result confirms a postsynaptic effect 
of the toxin on the nAChRs present in cochlear 
hair cells. A reduction in the frequency of events 
(from 2.2 ± 0.5 Hz to 1.2 ± 0.2 Hz, data not 
shown) was observed. This could be due either to 
the fact that the blocking action of the toxin on the 
synaptic events of small amplitudes could not be 
resolved within the noise of the recordings or to an 
additional presynaptic effect of the toxin. The 
latter was not further investigated. 
To assess the effect of α-CTx PeIA on 
non-α-bungarotoxin-sensitive neuronal nAChRs, 
concentration-response analysis was conducted on 
rat α2β4, α2β2, α4β2, α4β4, α3β2 and α3β4 (Fig 
6 and Table I).  The toxin had little or no activity 
when bath-applied on α2β4, α2β2 and α4β4 
nAChRs at concentrations as high as 10 µM.  The 
percent response ± S.E.M. to ACh was, 
respectively, 98.2 ± 2.1%, 95.3 ± 1.9%, and 91.4   
± 2.3% (n = 3).  Only a 39.2 ± 5.5 % (n = 4) block 
of α4β2 was observed in the presence of 10 µM α-
CTx PeIA. On the other hand, α-CTx PeIA 
appeared to be effective on α3-containing 
receptors, displaying a higher selectivity for α3β2 
(IC50 = 23 ± 1 nM, n = 5) than for α3β4 (IC50 = 
0.48 ± 0.03 µM, n = 4)  nAChRs. α-CTx PeIA was 
also tested on rat  α6/α3β2β3 nAChRs, where 
α6/α3 is a chimeric alpha subunit containing the 
N-terminal 237 amino acids of α6 and the 
remainder of  α3 (33).  The toxin at 100 nM 
blocked   89.8 ± 1.8% of the response (n=4). 
 Nicotinic AChRs are members of the 
“Cys-loop” family of neurotransmitter-gated ion 
channels, which also includes GABAA, GABAC, 
glycine, 5-HT3 and some invertebrate anionic 
glutamate receptors (34). In order to assess the 
selectivity of α-CTx PeIA for nAChRs, we tested 
the effect of the toxin on some other members of 
the family, such as the GABAA and 5-HT3A 
receptors. Concentrations of α-CTx PeIA as high 
as 10 µM did not modify responses to 30 µM γ-
aminobutyric acid or 10 µM serotonin in oocytes 
injected with the respective recombinant receptors 
(n = 4), thus confirming the selectivity of this α-
conotoxin from Conus pergrandis on nAChRs. 
The mature toxin sequence of α-CTx PeIA 
bears high resemblance to α-conotoxins MII (α-
CTx MII) and GIC (α-CTx GIC) isolated from 
Conus magus and Conus geographus, respectively 
(Table 2).  While α-CTx MII potently targets α3- 
and α6-containing neuronal nAChRs, α-CTx GIC 
has a higher selectivity for α6-containing receptors 
(35). We therefore examined the effect of these 
toxins in α9α10-expressing oocytes.  At a 10 µM 
concentration, neither α-CTx MII nor α-CTx GIC 
blocked α9α10 nAChRs (n = 3). 
 
DISCUSSION 
 
By utilizing conserved sequences in 
conotoxin genes, we have cloned a gene encoding 
a novel peptide of the α-conotoxin family from 
Conus pergrandis. This species was only very 
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rarely collected, and once regarded among the ten 
most valuable Conus species for shell collectors 
(36). In recent years, however, commercial 
collectors in the Central Philippines have collected 
a moderate number of specimens.  α-CTx PeIA is 
the first toxin to be characterized form this species 
and adds to the arsenal of peptides active at 
nAChRs that have been isolated from Conus. 
Thus, Conus pergrandis represents a new source 
of useful pharmacological probes to characterize 
nAChRs. We note, however, that the peptide has 
not yet been isolated from the venom of Conus 
pergrandis, and it is possible that the native 
venom-derived peptide has posttranslational 
modifications not evident from inspection of the 
genetic sequence.  In this report, we describe the 
properties of a synthetic version of the putative 
conotoxin.  The peptide is 16 residues in length, 
with two disulfide bonds. α-CTx PeIA belongs to 
the A superfamily, as do the majority of Conus 
peptides that are known to affect the function of 
nAChRs (37). The spacing between Cys residues, 
four amino acids in the first loop and seven in the 
second loop, is typical of several previously 
isolated α-conotoxins of the α4/7 family like MII 
and GIC, which preferentially target non-muscle 
nAChRs (18, 35). 
α-CTx PeIA selectively targets the α-
bungarotoxin-sensitive α9α10 rather than α7 
nAChRs.  α9α10 nAChRs pharmacologically 
differ from α7 in that nicotine and ICS 205-930 
block the former whereas they activate the latter 
(7, 38). In addition, strychnine, a well-
characterized glycine antagonist, potently blocks 
α9α10 and α7 nAChRs, with a lower IC50 for 
α9α10 (7, 39, 40). α-CTx PeIA is the first 
reported conotoxin to block α9α10 nAChRs with 
high affinity. Similar to some previously 
characterized α4/7 family conotoxins, including 
α-CTx MII and α-CTx GIC, α-CTx PIA also 
potently blocks the α3β2 nAChR.  In contrast, 
however, α-CTx MII and α-CTx GIC show no 
activity at α9α10 nAChRs at concentrations of up 
to 10 µM. 
Current data supports the notion that a 
receptor assembled from both α9 and α10 nAChR 
subunits mediates synaptic transmission between 
efferent olivocochlear fibers and cochlear hair 
cells (3, 7, 28, 29, 41). However, α7 transcripts as 
well as α7 immunostaining have been reported in 
the mammalian organ of Corti (30, 31).The fact 
that native hair cell nAChRs were potently 
blocked by α-CTx PeIA, precludes the 
participation of α7 nAChRs in mediating ACh-
evoked responses in inner hair cells. The situation 
for other tissues remains to be determined. Dorsal 
root ganglion neurons express multiple nAChR 
subtypes, including α7-like, α3β4-like and α4β2-
like (42).  They also co-express both α9 and α10 
subunits (43, 44). In addition, peripheral blood 
lymphocytes and developing thymocytes have 
been shown to express cholinergic receptors, 
including the nAChR subunits α2–5, α7, α9, α10 
and β4, that could participate at different steps in 
the regulation of the immune response (45-47). 
Finally, α7, α9 and α10 are expressed in skin 
keratinocytes and might be involved at different 
steps in the regulation of skin homeostasis (48-51). 
The observation that α-CTx PeIA has a 260-fold 
selectivity for α9α10 compared to α7, indicates 
that it is a useful probe to differentiate responses 
mediated either through α9α10 or α7 nAChRs in 
the above mentioned tissues where both receptors 
are expressed. 
The carnivorous marine snails of the genus 
Conus are a rich source of peptides targeted to 
nAChRs. A major component of the complex 
venomous arsenal that the fish-eating Conus 
employ, are toxins that act at the muscle nicotinic 
receptor type (18). Why might these snails have 
evolved a toxin with high affinity for α9α10 
receptors? Conus pergrandis is found in deep 
waters (50-530 m) of the Western Pacific. The 
feeding habits of Conus pergrandis are unknown, 
but Conus species in general prey upon fish, 
 by guest on July 19, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
α-CTx PeIA discriminates between α9α10 and α7 nAChRs 
8 
mollusks and/or worms.  Little is known about the 
nAChR subtypes found in these prey.  However, 
the Fugu rubripes (pufferfish) genome contains 
three candidate α7, two α8 and four α9 subunit 
genes. Moreover, it has been described that this 
fish genome contains the largest family of 
vertebrate nAChR subunits reported to date (52). 
In addition three α9 subunit genes have been 
described in the rainbow trout (Oncorhynchus 
mykiss) (53). Although, none of the Fugu nAChR 
sequences show close identity to the mammalian 
or avian α10 subunits, three of the α9-like 
subunits possess glycosylation sites also found in 
the higher vertebrate α10 subunit (52), suggesting 
that these α9-like subunits might co-assemble to 
form a functional nAChR, much like the higher 
vertebrate homomeric α9 and/or heteromeric 
α9α10 nAChRs.  Higher vertebrate α9 and α9α10 
nAChRs mediate efferent cholinergic inhibition at 
cochlear and vestibular hair cells (3, 7, 28, 29, 41). 
The cholinergic pharmacology of efferent block in 
the fish lateral line organ is similar to that in hair 
cells of the cochlea, indicating that the same 
nicotinic cholinergic receptor is likely involved 
(54) (55). The proper orientation of 
mechanosensory hair cells along the lateral-line 
organ of a fish is essential for the animal's ability 
to sense directional water movements. This 
sensory system appears to be important in many 
behavioral tasks such as prey capture, orientation 
with respect to external environmental cues, 
navigation in low-light conditions, and mediation 
of interactions with nearby animals (56-59) Thus, 
block of efferent modulation of the lateral line 
activity by Conus toxins could facilitate prey 
capture by these  predatory snails. 
α-CTx PeIA shows considerable sequence 
similarity to the α4/7 α-conotoxins MII and GIC 
(26). The comparison of the structure of α-CTx 
PeIA, MII and GIC, indicates that the four Cys 
residues are identically placed having the same 
disulfide connectivity. Moreover, a conserved 
proline and the identical placement of an histidine 
and an asparagine that are known to either initiate 
or immediately precede an α-helix in GIC and 
MII, indicate that the peptide backbone topology 
of α-CTx PeIA is likely similar to that of the other 
two α-conotoxins. Indeed, when compared as a 
group, there are only four non-conservative amino 
acid substitutions among the three peptides (see 
bold residues in Table 2). The α4/7 toxins have a 
common structural scaffold. Their polypeptide 
backbones appear to be virtually identical: the 
canonical α helical structure and two β turns are 
prominent structural features of the family. Given 
the near identity of the peptide backbones the 
ability of the different α4/7 Conus peptides to 
discriminate between different neuronal nAChR 
subtypes must clearly be mediated through their 
divergent side-chain groups (18). Although all 
three toxins, MII, GIC and PeIA, have high 
affinity for the α3β2 nAChR (35, 60), only α-CTx 
PeIA has high affinity for α9α10. Thus, the amino 
acids shown in bold in Table 2 are likely structural 
determinants of the high selectivity of α-CTx 
PeIA for α9α10 nAChRs.  
Conclusion-A remarkable accomplishment 
of the Conus genus has been the evolution of 
nAChR antagonist of diverse subtype specificities. 
The diversity of their venom products is likely a 
consequence of the complex marine environment 
in which these slow-moving and otherwise 
unarmed predators must compete. Conus hunt a 
broad range of organisms (five different phyla) 
and also must defend themselves against 
crustaceans and other predators. We have now 
identified a novel peptide, α-CTx PeIA, that 
selectively targets the most recently identified 
nAChR subunits, α9 and α10. Thus, isolation of 
peptides from Conus venoms continues to prove 
useful to identify novel pharmacological tools to 
characterize the nAChR family. 
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AM, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid-acetoxymethyl ester; acetylcholine, ACh; 
MALDI, Matrix-assisted laser desorption ionization. 
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Fig. 1. Prepropeptide and encoded toxin of  α-Ctx PeIA. A putative proteolityc processing site 
following the basic residue R is denoted. The mature toxin is indicated. The glycine following the C-
terminal cysteine in the mature toxin is presumed to be processed to a C-terminal amide. 
 
 
Fig. 2. Effect of α-CTx PeIA on α9α10 and α7 nAChRs. A, representative traces of the response to 
ACh either alone or in the presence of α-CTx PeIA. B, inhibition curves performed by the co-application 
of 10 µM (α9α10) or 100 µM ACh (α7) and increasing concentrations of α-CTx PeIA. Oocytes were 
incubated with each concentration of the toxin for 10 min prior to the addition of ACh. Peak current 
values are plotted, expressed as the percentage of the peak control current evoked by ACh. The mean and 
S.E.M. of five to six experiments per group are shown. 
 
Fig. 3. Wash-out kinetics of α-CTx PeIA from α9α10 receptors. After a control response to 10 µM 
ACh was obtained, 1 µM α-CTx PeIA was applied to α9α10 expressing oocytes for 10 minutes. The 
oocyte was then continuously perfused with saline solution without toxin while responses to ACh were 
recorded. Similar results were obtained in three other experiments. 
 
Fig. 4. Effect of α-CTx PeIA on ACh-evoked currents of inner hair cells. A, representative traces to 
60 µM ACh either alone or in the presence of α-CTx PeIA. B, inhibition curves performed by the co-
application of 60 µM ACh and increasing concentrations of α-CTx PeIA. Cells were incubated with each 
concentration of the toxin for 10 min prior to the addition of ACh. Peak current values are plotted, 
expressed as the percentage of the peak control current evoked by ACh. The mean and S.E.M. of four to 
six cells per point are shown. 
 
Fig. 5. Effect of α-CTx PeIA on inner hair cell synaptic currents. A, representative traces of the effect 
of 30 nM α-CTx PeIA on synaptic currents evoked by 25 mM KCl. The insets show synaptic currents on 
an expanded time scale. B, bar diagram showing the effect of 30 nM α-CTx PeIA on the amplitude of 
synaptic currents. The recordings are from three independent inner hair cells and the number of analyzed 
events were 997 and 766, either in the absence or the presence of α-CTx PeIA, respectively. The asterisk 
denotes a significant difference, p < 0.0001. 
 
Fig. 6. Effect of α-CTx PeIA on α3β2, α3β4 and α4β2 nAChRs. Inhibition curves obtained by the co-
application of 10 µM (α3β2), 100 µM (α3β4)  or 10 µM ACh (α4β2) and increasing concentrations of α-
CTx PeIA. Oocytes were incubated with each concentration of the toxin for 10 min prior to the addition 
of ACh. Peak current values are plotted, expressed as the percentage of the peak control current evoked 
by ACh. The mean and S.E.M. of four to five experiments per group are shown. 
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Table  1: Effects of α-Ctx PeIA on nAChRs 
 
IC50 (nM)       CI           Hill slope CI  n 
 
α9 α10     6.9         5.2 - 9.1  0.88       0.74 - 1.02  6 
 
α7    1,800  1,396 – 2,206  1.10       0.86 - 1.33 5 
 
α3β2       23    19.2 - 27.5  1.25       0.97 - 1.50 5 
 
α3β4      480     372 - 640  1.23       0.89 - 1.58 4 
 
α4β2   11,600 8,811 – 15,170 3.02       1.76 - 7.81 3 
 
IC50: concentration of toxin that produces 50% of block; CI: 95% confidence interval;    
n: number of experiments. In the case of α4β2, the IC50 was derived from the regression.  
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Table 2. Sequence comparison of α-conotoxins 
 
 α-Conotoxin Sequence IC50 α9α10 (nM) 
    
 PeIA GCCSHPACSVNHPELC 6.7 
 MII GCCSNPVCHLEHSNLC >10,000 
 GIC GCCSHPACAGNNQHIC >10,000 
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